» Articles » PMID: 1279519

Group I Permuted Intron-exon (PIE) Sequences Self-splice to Produce Circular Exons

Overview
Specialty Biochemistry
Date 1992 Oct 25
PMID 1279519
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Circularly permuted group I intron precursor RNAs, containing end-to-end fused exons which interrupt half-intron sequences, were generated and tested for self-splicing activity. An autocatalytic RNA can form when the primary order of essential intron sequence elements, splice sites, and exons are permuted in this manner. Covalent attachment of guanosine to the 5' half-intron product, and accurate exon ligation indicated that the mechanism and specificity of splicing were not altered. However, because the exons were fused and the order of the splice sites reversed, splicing released the fused-exon as a circle. With this arrangement of splice sites, circular exon production was a prediction of the group I splicing mechanism. Circular RNAs have properties that would make them attractive for certain studies of RNA structure and function. Reversal of splice site sequences in a context that allows splicing, such as those generated by circularly permuted group I introns, could be used to generate short defined sequences of circular RNA in vitro and perhaps in vivo.

Citing Articles

Characterization of group I introns in generating circular RNAs as vaccines.

Liao K, Eshaghi M, Hong Z, Saw T, Lim J, Han J Nucleic Acids Res. 2025; 53(4).

PMID: 40036878 PMC: 11879131. DOI: 10.1093/nar/gkaf089.


Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.

Hatzimanolis O, Sykes A, Cristino A Mol Psychiatry. 2025; .

PMID: 39966624 DOI: 10.1038/s41380-025-02925-1.


Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach.

Bu T, Yang Z, Zhao J, Gao Y, Li F, Yang R Int J Mol Sci. 2025; 26(1.

PMID: 39796233 PMC: 11722184. DOI: 10.3390/ijms26010379.


Viroids and Retrozymes: Plant Circular RNAs Capable of Autonomous Replication.

Lezzhov A, Atabekova A, Chergintsev D, Lazareva E, Solovyev A, Morozov S Plants (Basel). 2025; 14(1.

PMID: 39795321 PMC: 11722881. DOI: 10.3390/plants14010061.


The therapeutic potential of circular RNAs.

OLeary E, Jiang Y, Kristensen L, Hansen T, Kjems J Nat Rev Genet. 2025; .

PMID: 39789148 DOI: 10.1038/s41576-024-00806-x.


References
1.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

2.
Cech T, Bass B . Biological catalysis by RNA. Annu Rev Biochem. 1986; 55:599-629. DOI: 10.1146/annurev.bi.55.070186.003123. View

3.
Kos A, Dijkema R, Arnberg A, van der Meide P, Schellekens H . The hepatitis delta (delta) virus possesses a circular RNA. Nature. 1986; 323(6088):558-60. DOI: 10.1038/323558a0. View

4.
Inoue T, Sullivan F, Cech T . New reactions of the ribosomal RNA precursor of Tetrahymena and the mechanism of self-splicing. J Mol Biol. 1986; 189(1):143-65. DOI: 10.1016/0022-2836(86)90387-6. View

5.
Price J, Engberg J, Cech T . 5' exon requirement for self-splicing of the Tetrahymena thermophila pre-ribosomal RNA and identification of a cryptic 5' splice site in the 3' exon. J Mol Biol. 1987; 196(1):49-60. DOI: 10.1016/0022-2836(87)90510-9. View